ex-HSP and mHSP play immunogenic roles recognized by APCs, leading to T cell cross-priming, as well as by CD94+ NK cells, leading to tumor cytolysis, whereas ex-HSP/CD91 signaling in cancer cells promotes cancer progression. This evidence concerns the gene LRP1 and cancer.